186 related articles for article (PubMed ID: 27161381)
1. Factors influencing pleural drainage in parapneumonic effusions.
Porcel JM; Valencia H; Bielsa S
Rev Clin Esp (Barc); 2016 Oct; 216(7):361-366. PubMed ID: 27161381
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
Manuel Porcel J; Vives M; Esquerda A; Ruiz A
Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
[TBL] [Abstract][Full Text] [Related]
3. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
[TBL] [Abstract][Full Text] [Related]
4. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
Lung; 2006; 184(3):141-5. PubMed ID: 16902838
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.
Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM
Lung; 2014 Aug; 192(4):577-81. PubMed ID: 24913743
[TBL] [Abstract][Full Text] [Related]
6. Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema.
Yang CY; Kuo YH; Chen M; Wang CL; Shih LJ; Liu YC; Hsueh PC; Lai YH; Chu CM; Wu CC; Wu KA
Sci Rep; 2021 Jan; 11(1):1763. PubMed ID: 33469074
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
Porcel JM; Vives M; Esquerda A
Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography scoring system for discriminating between parapneumonic effusions eventually drained and those cured only with antibiotics.
Porcel JM; Pardina M; Alemán C; Pallisa E; Light RW; Bielsa S
Respirology; 2017 Aug; 22(6):1199-1204. PubMed ID: 28370693
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
10. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
[TBL] [Abstract][Full Text] [Related]
11. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.
Kho SS; Chan SK; Yong MC; Cheah HM; Lee YG; Tie ST
Respir Investig; 2020 Sep; 58(5):367-375. PubMed ID: 32107195
[TBL] [Abstract][Full Text] [Related]
14. [Parapneumonic pleural effusions and empyema in adults:current practice].
Porcel JM; Light RW
Rev Clin Esp; 2009 Nov; 209(10):485-94. PubMed ID: 19889319
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing complicated from uncomplicated parapneumonic effusions.
Porcel JM
Curr Opin Pulm Med; 2015 Jul; 21(4):346-51. PubMed ID: 26016577
[TBL] [Abstract][Full Text] [Related]
16. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.
Chung CL; Hsiao SH; Hsiao G; Sheu JR; Chen WL; Chang SC
PLoS One; 2013; 8(1):e53169. PubMed ID: 23308155
[TBL] [Abstract][Full Text] [Related]
17. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
18. Pleural effusions caused by infection.
Varkey B
Postgrad Med; 1986 Oct; 80(5):213-6, 219, 222-3. PubMed ID: 3763525
[TBL] [Abstract][Full Text] [Related]
19. Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.
Lee J; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Infection; 2017 Feb; 45(1):59-65. PubMed ID: 27488820
[TBL] [Abstract][Full Text] [Related]
20. Management of Parapneumonic Pleural Effusion in Adults.
Ferreiro L; San José ME; Valdés L
Arch Bronconeumol; 2015 Dec; 51(12):637-46. PubMed ID: 25820035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
